Sou Hu Cai Jing·2026-02-27 15:35Group 1 - The core viewpoint of the article highlights the strong financial performance of Chunli Medical, with significant growth in revenue and net profit for the fiscal year 2025 [1] Group 2 - Chunli Medical's total revenue for 2025 reached approximately 1.04 billion yuan, representing a year-on-year increase of 29.52% [1] - The net profit attributable to the parent company was approximately 272.12 million yuan, showing a remarkable year-on-year growth of 117.72% [1] - As of the end of the reporting period, total assets amounted to approximately 3.66 billion yuan, reflecting a growth of 5.58% compared to the beginning of the period [1] - The equity attributable to the parent company was approximately 2.99 billion yuan, which is a 5.86% increase from the start of the period [1] - The growth in performance is primarily attributed to increased sales following the implementation of product centralized procurement, expansion of international business, and optimization of operational efficiency [1]